This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Centene's (CNC) Q4 Earnings Miss Estimates, Improve Y/Y
by Zacks Equity Research
Centene's (CNC) fourth-quarter results gain traction from better revenues.
Centene (CNC) Q4 Earnings Miss Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of -1.35% and 2.19%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Centene's (CNC) Earnings in Q4?
by Zacks Equity Research
Centene's (CNC) Q4 earnings results are likely to reflect membership growth and better revenues.
Centene (CNC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Centene Corporation (CNC) a Good Value Investor Pick Now?
by Zacks Equity Research
Let's see if Centene Corporation (CNC) stock is a good choice for value-oriented investors right now from multiple angles.
Will Centene (CNC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Centene (CNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
UnitedHealth (UNH) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
UnitedHealth's (UNH) Q4 earnings are likely to have benefited from its operating segments and membership growth.
Molina Healthcare to Boost Medicaid Via Strategic Buyout
by Zacks Equity Research
Molina Healthcare (MOH) aims to scale up its Medicaid business by acquiring NextLevel Health.
Magellan Health's Arm Expands Its Suite of Health Solutions
by Zacks Equity Research
Magellan Health's (MGLN) subsidiary Magellan Complete Care of Virginia adds to its range of services to help patients achieve better health outcomes.
Humana (HUM) Grows on Strong Medicare Business Expansion
by Zacks Equity Research
Humana (HUM) thrives well on the back of its well-performing Medicare business.
Centene (CNC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Centene (CNC) closed the most recent trading day at $61.93, moving +0.1% from the previous trading session.
Centene (CNC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Centene (CNC) closed at $58.64, marking a -1.64% move from the previous day.
6 Trade-Proof Sector ETFs to Follow if No Deal is Cracked
by Sanghamitra Saha
These sector ETFs are almost trade-resistant and thus unlikely to suffer if no deal is cracked before Dec 15.
Humana (HUM) vs. Anthem (ANTM): Which is Better Placed?
by Zacks Equity Research
Humana (HUM) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On a comparative evaluation, we try to discover which is a more profitable bet based on the fundamentals.
Centene (CNC) Divests IlliniCare as Part of Merger Agreement
by Zacks Equity Research
Centene (CNC) inks a deal to divest IlliniCare to CVS Health to facilitate the pre-announced merger agreement.
CVS Health Set to Acquire Centene's IlliniCare Health Plan
by Zacks Equity Research
CVS Health's (CVS) latest collaboration with Centene is set to expand its Medicaid and Medicare Advantage presence in Illinois.
Why Should You Hold Centene (CNC) Stock in Your Portfolio?
by Zacks Equity Research
Acquisitions, rising revenues, growing membership and solid capital position carve out a long-term growth story for Centene (CNC).
Why Is Centene (CNC) Up 22.9% Since Last Earnings Report?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Healthcare Stocks in Focus on Price Transparency Rule
by Sapna Bagaria
Hospital stocks gain from a less-than-expected strict price transparency rule and health insurers' optimism on a likely rise in profitability from a low-cost plan.
Genesis Healthcare's (GEN) Q3 Earnings Beat, Improve Y/Y
by Zacks Equity Research
Genesis Healthcare's (GEN) third-quarter results reflect same store occupancy growth, partly offset by lower revenues.
Humana's (HUM) Q3 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) third-quarter results reflect higher revenues as well as solid membership growth.
Tenet Healthcare (THC) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings gain from its Hospital and Other segment as well as volume growth.
MEDNAX (MD) Q3 Earnings In Line With Estimates, Decline Y/Y
by Zacks Equity Research
MEDNAX's (MD) results reflect escalating expenses in the third quarter.
Healthcare ETF (IHF) Tops in October: 5 Best Stocks
by Sweta Killa
Inside the best performing stocks of the top ETF of October.
Ensign Group's (ENSG) Q3 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) third-quarter earnings suffer escalating expenses.